Satish Garg, H Peter Chase. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AdolescentBlood Glucose/drug effectsCircadian Rhythm/drug effectsCross-Over StudiesDiabetes Mellitus, Type 1/drug therapyHumansHypoglycemia/chemically inducedHypoglycemia/prevention & controlHypoglycemic Agents/administration & dosageHypoglycemic Agents/adverse effectsInsulin/administration & dosageInsulin/adverse effectsInsulin/analogs & derivativesInsulin GlargineInsulin LisproInsulin, Long-ActingRandomized Controlled Trials as Topic
Substances： See more » Blood GlucoseHypoglycemic AgentsInsulinInsulin LisproInsulin, Long-ActingInsulin Glargine
Year: 2004 PMID： 15237718 DOI： 10.1515/jpem.2004.17.5.805
Source DB: PubMed Journal: J Pediatr Endocrinol Metab ISSN： 0334-018X Impact factor: 1.634